{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:36Z","timestamp":1791520836446,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf00877755","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T00:33:35Z","timestamp":1104194015000},"page":"145-149","source":"Crossref","is-referenced-by-count":167,"title":["?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy"],"prefix":"10.1007","volume":"9","author":[{"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","unstructured":"The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure.N Engl J Med 1987;316:1429?1435.","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"295","author":"SOLVD Investigators","year":"1991","unstructured":"SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure.N Engl J Med 1991;295:293?302.","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","volume":"325","author":"JN Cohn","year":"1991","unstructured":"Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.N Engl J Med 1991;325:303?310.","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction.N Engl J Med 1992;327:669?677.","journal-title":"N Engl J Med"},{"key":"CR5","first-page":"821","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure.Lancet 1993;342:821?828.","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-N","volume":"340","author":"S Yusuf","year":"1992","unstructured":"Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.Lancet 1992;340:1173?1178.","journal-title":"Lancet"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","volume":"2","author":"Captopril Multicenter Research Group","year":"1983","unstructured":"Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure.J Am Coll Cardiol 1983;2:755?763.","journal-title":"J Am Coll Cardiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1988.03720040031022","volume":"259","author":"The Captopril-Digoxin Multicenter Research Group","year":"1988","unstructured":"The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild-to-moderate heart failure.JAMA 1988;259:539?544.","journal-title":"JAMA"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0735-1097(93)90454-9","volume":"22","author":"R Garg","year":"1993","unstructured":"Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: Evolution of a major public health problem in cardiovascular medicine.J Am Coll Cardiol 1993;22:3A-5A.","journal-title":"J Am Coll Cardiol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","volume":"91","author":"J Staessen","year":"1981","unstructured":"Staessen J, Lijnen P, Fagard R, et al. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.J Endocrinol 1981;91:457?465.","journal-title":"J Endocrinol"},{"key":"CR11","unstructured":"Mareyev V, Skvortsov A, Masenko V, Belenkov Y. Escape of ACE inhibitor effects on aldosterone during long-term treatment of congestive heart failure. Abstract to be presented at the International Meeting on Heart Failure, Amsterdam, April 1995."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00005344-199302000-00015","volume":"21","author":"JC Aldigier","year":"1993","unstructured":"Aldigier JC, Huang H, Dalmay F, et al. Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans.J Cardiovasc Pharmacol 1993;21:289?295.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","volume":"33","author":"C Borghi","year":"1993","unstructured":"Borghi C, Boschi S, Ambrosioni E, Melandri G, Branzi A, Magnani B. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors.J Clin Pharmacol 1993;33:40?45.","journal-title":"J Clin Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","unstructured":"Pouleur H, Konstam MA, Benedict CR, et al. Progression of left ventricular dysfunction during enalapril therapy: Relationship with neuro-hormonal reactivation.Circulation 1993;88:I-293.","DOI":"10.1161\/01.CIR.88.5.2277"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00004872-199311000-00001","volume":"11","author":"A Husain","year":"1993","unstructured":"Husain A. The chymase-angiotensin system in humans.J Hypertens 1993;11:1155?1159.","journal-title":"J Hypertens"},{"issue":"Suppl 7","key":"CR16","first-page":"S13","volume":"10","author":"VJ Dzau","year":"1992","unstructured":"Dzau VJ. Vascular renin angiotensin pathways: A new therapeutic target.J Cardiovasc Pharmacol 1992;10(Suppl 7):S13-S26.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","unstructured":"Weber KT, Villarreal D, Griffing GT.Heart Failure: Pathophysiology, Aldosterone and Anti-aldosterone therapy. GD Searle & Co., 1993.","DOI":"10.1016\/0002-9149(93)90238-8"},{"key":"CR18","volume-title":"The Renin-Angiotensin System","author":"JIS Robertson","year":"1993","unstructured":"Robertson JIS, Nicholls MG.The Renin-Angiotensin System. London: Gower Medical, 1993."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI104492","volume":"41","author":"JO Davis","year":"1962","unstructured":"Davis JO, Hartroft PM, Titus EO, et al. The role of the renin-angiotensin system in the control of aldosterone secretion.J Clin Invest 1962;41:378?389.","journal-title":"J Clin Invest"},{"key":"CR20","first-page":"63","volume":"9","author":"J Muller","year":"1986","unstructured":"Muller J. Spironolactone in the management of congestive cardiac failure: A review.Clin Ther 1986;9:63?76.","journal-title":"Clin Ther"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.HYP.13.6.706","volume":"13","author":"AJ Naftilan","year":"1989","unstructured":"Naftilan AJ, Pratt RE, Eldridge CS, et al. Angiotensin II induces c-fos expression in smooth muscle cell via transcriptional control.Hypertension 1989;13:706?711.","journal-title":"Hypertension"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.HYP.19.2.131","volume":"19","author":"Y Dohi","year":"1992","unstructured":"Dohi Y, Hahn AWA, Boulanger CM, et al. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.Hypertension 1992;19:131?137.","journal-title":"Hypertension"},{"key":"CR23","first-page":"1255","volume":"130","author":"B Rydzewski","year":"1992","unstructured":"Rydzewski B, Zelezna B, Tang W, et al. Angiotensin II stimulation of plasminogen activator inhibitor-I gene expression in astroglial cells from the brain.Endocrinology 1992;130:1255?1262.","journal-title":"Endocrinology"},{"key":"CR24","first-page":"245","volume":"8","author":"S Keidar","year":"1993","unstructured":"Keidar S, Brook JG, Aviram M. Angiotensin II enhances lipid peroxidation of low-density lipoprotein.News Physiol Sci 1993;8:245?248.","journal-title":"News Physiol Sci"},{"key":"CR25","volume-title":"The Renin-Angiotensin System","author":"JE Hall","year":"1993","unstructured":"Hall JE, Brands MW. Intrarenal and circulating angiotensin II and renal function. In: Robertson JIS, Nicholls MG, eds.The Renin-Angiotensin System. Gower Medical, London, 1993."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system.Circulation 1991;83:1849?1865.","journal-title":"Circulation"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90238-8","volume":"71","author":"KT Weber","year":"1993","unstructured":"Weber KT, Villareal D. Aldosterone and antialdosterone therapy in congestive heart failure.Am J Cardiol 1993;71:3A-11A.","journal-title":"Am J Cardiol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.0954-6820.1986.tb18112.x","volume":"707","author":"PO Wester","year":"1986","unstructured":"Wester PO, Dyckner T. Intracellular electrolytes in cardiac failure.Acta Med Scand 1986;707:33?36.","journal-title":"Acta Med Scand"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0002-8703(92)90633-7","volume":"124","author":"MJ Eisenberg","year":"1992","unstructured":"Eisenberg MJ. Magnesium deficiency and sudden death.Am Heart J 1992;124:544?549.","journal-title":"Am Heart J"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archinte.1985.00360090162024","volume":"145","author":"R Whang","year":"1985","unstructured":"Whang R, Flink EB, Dyckner T, Wester PO, Aikawa JK, Ryan MP. Magnesium depletion as a cause of refractory potassium repletion.Arch Intern Med 1985;145:1686?1689.","journal-title":"Arch Intern Med"},{"key":"CR31","unstructured":"Barr CS, Hanson J, Kennedy N, Lang CC, Struthers AD. The effect of a mineralocorticoid antagonist on myocardial mIBG uptake in congestive heart failure.Circulation 1993;88:I-256."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","unstructured":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med 1989;321:406?412.","journal-title":"N Engl J Med"},{"key":"CR33","first-page":"VI24","volume":"87","author":"S Goldman","year":"1993","unstructured":"Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G, for the V-HeFT VA Cooperative Studies Group. Mechanism of death in heart failure. The vasodilator-heart failure trials.Circulation 1993;87:VI24?VI-31.","journal-title":"Circulation"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"The SOLVD Investigators","year":"1992","unstructured":"The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction.N Engl J Med 1992;327:685?691.","journal-title":"N Engl J Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00878518","volume":"7","author":"M Texter","year":"1993","unstructured":"Texter M, Lees RS, Pitt B, et al. The Quinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention.Cardiovasc Drugs Ther 1993;7:273?282.","journal-title":"Cardiovasc Drugs Ther"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(91)90410-M","volume":"68","author":"FR Bauwens","year":"1991","unstructured":"Bauwens FR, Duprez DA, DeBuyzere ML, et al. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension.Am J Cardiol 1991;68:925?929.","journal-title":"Am J Cardiol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.81.1.238","volume":"81","author":"R Karam","year":"1990","unstructured":"Karam R, Healy BP, Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy.Circulation 1990;81:238?246.","journal-title":"Circulation"},{"key":"CR38","unstructured":"Yuen JL, Wu J, Nanna M, et al. Coronary vascular reserve is substantially reduced in dilated cardiomyopathy independently from the presence or absence of coronary artery disease.J Am Coll Cardiol 1993;21:364A."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.HYP.21.6.929","volume":"21","author":"S Taddei","year":"1993","unstructured":"Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension 1993;21:929?933.","journal-title":"Hypertension"},{"issue":"Suppl II","key":"CR40","first-page":"74","volume":"61","author":"DG Harrison","year":"1987","unstructured":"Harrison DG, Freiman PC, Mitchell GG, et al. Alterations of vascular reactivity in atherosclerosis.Circ Res 1987;61(Suppl II):74?80.","journal-title":"Circ Res"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.CIR.81.3.772","volume":"3","author":"CB Treasure","year":"1990","unstructured":"Treasure CB, Vita JV, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.Circulation 1990;3:772?779.","journal-title":"Circulation"},{"key":"CR42","first-page":"R1064","volume":"255","author":"KL Goetz","year":"1988","unstructured":"Goetz KL, Wang BC, Madwed JF, Zhu IL, Leadley RJ. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs.Am J Physiol 1988;255:R1064-R1068.","journal-title":"Am J Physiol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(89)90227-X","volume":"78","author":"Y Hirata","year":"1989","unstructured":"Hirata Y, Takagi, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells.Atherosclerosis 1989;78:225?228.","journal-title":"Atherosclerosis"},{"key":"CR44","first-page":"27","volume":"6","author":"L Lind","year":"1992","unstructured":"Lind L, Lithell H, Wide L, et al. Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension.J Hum Hypertens 1992;6:27?29.","journal-title":"J Hum Hypertens"},{"key":"CR45","first-page":"E974","volume":"26","author":"M Wehling","year":"1992","unstructured":"Wehling M, Christ M, Theisen K. Membrane receptors for aldosterone: A novel pathway for mineralo-corticoid action.Endocrinol Metab 1992;26:E974-E979.","journal-title":"Endocrinol Metab"},{"key":"CR46","first-page":"E505","volume":"252","author":"M Wehling","year":"1987","unstructured":"Wehling M, Armanini D, Strasser T, et al. Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes.Endocrinol Metab 1987;252:E505-E508.","journal-title":"Endocrinol Metab"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.7361117","volume":"208","author":"PDMV Turlapaty","year":"1989","unstructured":"Turlapaty PDMV, Altuna BM. Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease.Science 1989;208:198?200.","journal-title":"Science"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/01.CIR.79.3.597","volume":"79","author":"H Miyagi","year":"1989","unstructured":"Miyagi H, Yasue H, Okumura K, et al. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina.Circulation 1989;79:597?602.","journal-title":"Circulation"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02454195","volume":"110","author":"WB Weglicki","year":"1992","unstructured":"Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin.Mol Cell Biochem 1992;110:169?173.","journal-title":"Mol Cell Biochem"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1631560","volume":"257","author":"MS Finkel","year":"1992","unstructured":"Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide.Science 1992;257:387?389.","journal-title":"Science"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","volume":"82","author":"GS Francis","year":"1990","unstructured":"Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure.Circulation 1990;82:1724?1729.","journal-title":"Circulation"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"39G","DOI":"10.1016\/0002-9149(89)90218-X","volume":"63","author":"SS Gottlieb","year":"1989","unstructured":"Gottlieb SS. Importance of magnesium in congestive heart failure.Am J Cardiol 1989;63:39G-42G.","journal-title":"Am J Cardiol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/01.CIR.80.3.573","volume":"80","author":"MA Ralston","year":"1989","unstructured":"Ralston MA, Murnane MR, Kelley RE, Altschuld RA, Unverferth DV, Leier CV. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure.Circulation 1989;80:573?580.","journal-title":"Circulation"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.296.6620.455","volume":"296","author":"I Dorup","year":"1988","unstructured":"Dorup I, Skajaa K, Clausen T, Kjeldsen K. Reduced concentrations of potassium, magnesium and sodium-potassium pumps in human skeletal muscle during treatment with diuretic.Br Med J 1988;296:455?458.","journal-title":"Br Med J"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/0002-9149(93)90986-M","volume":"72","author":"Y Bashir","year":"1993","unstructured":"Bashir Y, Sneddon JF, Staunton HA, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease.Am J Cardiol 1993;72:1156?1162.","journal-title":"Am J Cardiol"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","volume":"82","author":"K Swedberg","year":"1990","unstructured":"Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality.Circulation 1990;82:1730?1736.","journal-title":"Circulation"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","volume":"71","author":"AA Vliet van","year":"1993","unstructured":"van Vliet AA, Donker AJM, Nauta JJP, et al. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin converting enzyme inhibitor.Am J Cardiol 1993;71:21A-28A.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00877755\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T12:44:51Z","timestamp":1705495491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00877755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF00877755"],"URL":"https:\/\/doi.org\/10.1007\/bf00877755","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}